DNA Repair Drugs Market by Drug Type, Form, Mechanism of Action, Application, Distribution Channel - Global Forecast 2025-2030- Product Image

Sale

DNA Repair Drugs Market by Drug Type, Form, Mechanism of Action, Application, Distribution Channel - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 5977983

UP TO €692EUR$697USD£574GBP OFF until Dec 31^st 2024

The DNA Repair Drugs Market grew from USD 8.58 billion in 2023 to USD 9.18 billion in 2024. It is expected to continue growing at a CAGR of 7.20%, reaching USD 13.97 billion by 2030.

The scope of DNA repair drugs centers on their role in oncology, where they aim to exploit the cellular repair mechanisms that cancer cells rely on for survival. Defined as therapeutic agents targeting pathways like homologous recombination or non-homologous end joining, they are pivotal in personalizing cancer treatment. There is a vital necessity for these drugs, driven by rising cancer incidence and the emergence of resistance to existing therapies. They find applications in treating various cancers, including ovarian, breast, and prostate cancer, with use often aligned to patients' specific genetic repairs anomalies. The end-use scope spans pharmaceutical companies, research labs, and healthcare providers looking to optimize cancer treatment strategies. Key growth factors include advancements in genomic technologies, enabling precise targeting of DNA repair pathways, and the development of combination therapies that improve efficacy and reduce resistance. Opportunities abound in the increased investment in precision medicine and growing interest in poly (ADP-ribose) polymerase (PARP) inhibitors. Recommendations to seize these opportunities include investing in R&D for more specific inhibitors and collaborating with genetic testing firms to identify target patient populations. However, limitations such as the high cost of drug development, regulatory hurdles, and the potential for off-target effects remain challenges to market growth. Innovations could focus on developing cost-effective synthesis processes and leveraging AI for drug design to mitigate these hurdles. The market nature remains intensely competitive with rapid advancements, demanding agility and innovation. For business growth, identifying unmet needs such as rare genetic repair profiles in tumors can guide the development of next-generation inhibitors. Moreover, early collaboration with regulatory bodies can streamline approval processes, enhancing market entry speed.

Understanding Market Dynamics in the DNA Repair Drugs Market

The DNA Repair Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing incidences of chronic and genetic diseases across the world
- Expanding clinical trials and research initiatives to develop DNA repair drugs
- Government initiatives to promote access to treatments for complex diseases
Market Restraints
- Formulation issues and complexities of DNA repair drugs
Market Opportunities
- Ongoing innovations to improve the efficacy and safety of DNA repair drugs
- Consumer preference for personalized and precision strategies to manage complex diseases
Market Challenges
- Limitations associated with efficacy and safety concerns

Exploring Porter’s Five Forces for the DNA Repair Drugs Market

Porter’s Five Forces framework further strengthens the insights of the DNA Repair Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the DNA Repair Drugs Market

External macro-environmental factors deeply influence the performance of the DNA Repair Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the DNA Repair Drugs Market

The DNA Repair Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the DNA Repair Drugs Market

The DNA Repair Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the DNA Repair Drugs Market

The DNA Repair Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA Repair Drugs Market, highlighting leading vendors and their innovative profiles. These include Artios Pharma, AstraZeneca PLC, Aurigene Discovery Technologies, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CanBas Co., Ltd., Clovis Oncology, Corden Pharma International GmbH, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline PLC, Hanson Wade Group, Johnson & Johnson Services, Inc., Merck KgaA, Novartis AG, Pfizer Inc., and Valerio Therapeutics.

Market Segmentation & Coverage

This research report categorizes the DNA Repair Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Type
- Alkylating Agents
- Poly ADP Ribose Polymerase Inhibitors
Form
- Capsules
- Injectables
- Tablets
Mechanism of Action
- Base Excision Repair Modulators
- Double-strand Break Repair Modulators
- Mismatch Repair Modulators
- Single-strand Break Repair Modulators
Application
- Neurological Diseases
- Oncology
  - Breast Cancer
  - Ovarian Cancer
  - Prostate Cancer
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of chronic and genetic diseases across the world
5.1.1.2. Expanding clinical trials and research initiatives to develop DNA repair drugs
5.1.1.3. Government initiatives to promote access to treatments for complex diseases
5.1.2. Restraints
5.1.2.1. Formulation issues and complexities of DNA repair drugs
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the efficacy and safety of DNA repair drugs
5.1.3.2. Consumer preference for personalized and precision strategies to manage complex diseases
5.1.4. Challenges
5.1.4.1. Limitations associated with efficacy and safety concerns
5.2. Market Segmentation Analysis
5.2.1. Form: Significant adoption of injectables for quick delivery of medication
5.2.2. Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. DNA Repair Drugs Market, by Drug Type

6.1. Introduction
6.2. Alkylating Agents
6.3. Poly ADP Ribose Polymerase Inhibitors

7. DNA Repair Drugs Market, by Form

7.1. Introduction
7.2. Capsules
7.3. Injectables
7.4. Tablets

8. DNA Repair Drugs Market, by Mechanism of Action

8.1. Introduction
8.2. Base Excision Repair Modulators
8.3. Double-strand Break Repair Modulators
8.4. Mismatch Repair Modulators
8.5. Single-strand Break Repair Modulators

9. DNA Repair Drugs Market, by Application

9.1. Introduction
9.2. Neurological Diseases
9.3. Oncology
9.3.1. Breast Cancer
9.3.2. Ovarian Cancer
9.3.3. Prostate Cancer

10. DNA Repair Drugs Market, by Distribution Channel

10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies

11. Americas DNA Repair Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific DNA Repair Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa DNA Repair Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations
14.3.2. Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs
14.3.3. FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. DNA REPAIR DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DNA REPAIR DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DNA REPAIR DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DNA REPAIR DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 51. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 53. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 56. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 81. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 83. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 88. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 89. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 91. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 100. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 103. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 155. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 161. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 164. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 167. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 173. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 179. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 191. ITALY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 192. ITALY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 209. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 214. POLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 215. POLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 216. POLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 218. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 221. QATAR DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 222. QATAR DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 224. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 245. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 263. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the DNA Repair Drugs Market, which are profiled in this report, include:

Artios Pharma
AstraZeneca PLC
Aurigene Discovery Technologies
Bio-Rad Laboratories, Inc.
Bristol-Myers Squibb Company
CanBas Co., Ltd.
Clovis Oncology
Corden Pharma International GmbH
Eli Lilly and Company
Genentech, Inc.
GlaxoSmithKline PLC
Hanson Wade Group
Johnson & Johnson Services, Inc.
Merck KgaA
Novartis AG
Pfizer Inc.
Valerio Therapeutics

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.18 Billion
Forecasted Market Value ( USD ) by 2030	$ 13.97 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global
No. of Companies Mentioned	18

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3518EUR$3,545USD£2,920GBP €3909EUR$3,939USD£3,244GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6224EUR$6,272USD£5,166GBP €6915EUR$6,969USD£5,740GBP

Understanding Market Dynamics in the DNA Repair Drugs Market

Exploring Porter’s Five Forces for the DNA Repair Drugs Market

Applying PESTLE Analysis to the DNA Repair Drugs Market

Analyzing Market Share in the DNA Repair Drugs Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the DNA Repair Drugs Market

Strategic Recommendations for Success in the DNA Repair Drugs Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

DNA Repair Drugs Market Analysis & Forecast to 2024-2034

DNA Repair Drugs Global Market Report 2024

DNA Repair Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

DNA Repair Oncology Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

Chromatin and Genomic Instability in Cancer. International Review of Cell and Molecular Biology Volume 364

About the Market